QIMR Berghofer researchers have unveiled a groundbreaking 'Atlas of the Heart', an online resource called Cardiopedia-Ligand, which provides an unprecedented level of detail about the human heart's intricate workings. This map is a treasure trove for scientists, offering a comprehensive view of the chemical signals that govern heart function and how heart tissue responds to over 80 biological signals.
What makes this achievement truly remarkable is the methodology employed. The study, published in Cell Stem Cell, utilized miniature human heart tissues grown in the lab, known as human cardiac organoids. These organoids were used to test 87 signaling molecules interacting with heart cell receptors, providing a unique and detailed dataset.
The research team, led by Professor James Hudson, measured the strength of tissue contractions and the genes that were activated or deactivated for each treatment. This comprehensive approach has bridged the gap in understanding molecule signals and their effects, which were previously unmapped. Professor Hudson emphasizes the significance of this resource, stating that it fills a major gap in the field.
The atlas is freely accessible through an online portal, a bold move by the researchers to encourage global collaboration and innovation. This open-access approach allows scientists worldwide to explore and analyze the data, fostering a collaborative environment for research. As Dr. Janice Reid explains, the project's organoid platform enables the production of over a thousand organoids weekly, facilitating the study's rapid and comprehensive data collection.
This heart map is just the beginning of a larger initiative supported by the Snow Medical Foundation. While similar large datasets exist for diseases like cancer, the heart has been a neglected area. The researchers are now building models and pipelines to create resources for cardiovascular research, aiming to provide more precise answers about heart disease.
The next phase of the project involves screening 2,000 drug compounds to create an even more comprehensive map of heart biology and responses to potential therapies. The ultimate goal, as Professor Hudson envisions, is to enable personalized medicine, where patients' genetics and biomarkers are matched to effective drugs. This ambitious project represents a significant step forward in our understanding and treatment of heart disease, offering a promising future for medical advancements.
